Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy

Papillary renal cell carcinoma (PRCC) is the most common nonclear cell RCCs and is known to comprise two histological subtypes. PRCC2 is more aggressive and is molecularly distinct from the other subtypes. Despite this, PRCCs are treated together as one entity, and they show poor response to the cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleeb, Rola M., Farag, Mina, Lichner, Zsuzsanna, Brimo, Fadi, Bartlett, Jenni, Bjarnason, Georg, Finelli, Antonio, Rontondo, Fabio, Downes, Michelle R., Yousef, George M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165997/
https://www.ncbi.nlm.nih.gov/pubmed/29896907
http://dx.doi.org/10.1002/1878-0261.12346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165997/
https://www.ncbi.nlm.nih.gov/pubmed/29896907
http://dx.doi.org/10.1002/1878-0261.12346

Ejemplares similares